Stock futures mixed to end week

FAN Editor

Stock futures were mixed Friday after the U.S. Treasury moved to end some coronavirus pandemic lending programs given to the Federal Reserve that the central bank considered “essential.”

Continue Reading Below

Dow futures were off 61 points, a decline of 0.2%, but up from the lows of the session. The S&P 500 was off 0.1%, while the tech-heavy Nasdaq Composite rose by a similar amount.

Ticker Security Last Change Change %
I:DJI DOW JONES AVERAGES 29483.23 +44.81 +0.15%
SP500 S&P 500 3581.87 +14.08 +0.39%
I:COMP NASDAQ COMPOSITE INDEX 11904.713966 +103.11 +0.87%

After the close of trading Thursday, Treasury Secretary Steven Mnuchin wrote a letter to Fed Chairman Jerome Powell, asking the Fed to return the unused $455 billion given to it under the CARES Act to help the struggling U.S. economy.

The move was not expected by Fed officials, who immediately told Mnuchin the programs should be extended after Mnuchin’s letter was made public.

STOCKS SHRUG OFF LOSSES, TECH AND ENERGY LED TURNAROUND

COVID ACCELERATING

Cases of COVID-19 have accelerated in recent days, with the country reporting 170,161 new cases Wednesday, the second-highest daily figure. More than 11.7 million people have been infected by the virus, resulting in over 252,000 deaths, according to data compiled by Johns Hopkins University.

On Thursday, the Centers for Disease Control and Prevention recommended against traveling for the upcoming Thanksgiving holiday as cases surge nationwide.

HELP IS ON THE WAY

Despite the rising caseload in the country and around the world, “hope and help are on the way,” according to Health and Human Services Secretary Alex Azar.

Ticker Security Last Change Change %
PFE PFIZER INC. 36.19 -0.13 -0.36%
BNTX BIONTECH SE 94.93 +4.49 +4.96%
MRNA MODERNA INC. 92.77 +3.88 +4.36%

Drugmaker Pfizer said it’s filing for emergency use approval for its COVID-19 vaccine on Friday, and FOX Business previously reported that Moderna might do so as well. The two drug companies have each completed their Phase III trials for their drugs, which showed 95% and 94.% efficacy rates, respectively.

Pfizer is partnering with German drug company BioNTech on its drug, known as BNT162b2. Shares of BioNTech surged 5% early Friday, while Pfizer and Moderna were up 1.4% and 2.8%, respectively.

Gilead Sciences shares fell nearly 2% after the World Health Organization advised against using remdesivir for COVID-19 patients, noting there is no evidence it helps with survival. The U.S. FDA has previously approved remdesivir for treating COVID-19.

TRUMP ATTENDS ASIAN SUMMIT

President Trump will attend the Asia-Pacific Economic Cooperation (APEC) summit, hosted virtually by Malaysia, where he is expected to face off with his Chinese counterpart, Xi Jinping.

It will be the first time the two have spoken since Joe Biden was named president-elect after winning the requisite 270 electoral votes in this month’s U.S. presidential election. Xi recently congratulated Biden on his win.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

West Texas Intermediate crude oil fell 8 cents to $41.74 per barrel. In other commodities, gold rose slightly to $1,862.10 an ounce.

GET FOX BUSINESS ON THE GO BY CLICKING HERE 

Free America Network Articles

Leave a Reply

Next Post

Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine

Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. If Pfizer’s application is approved, the vaccine will likely be limited and rolled out in phases, with health-care workers, the elderly and people with underlying health conditions getting the […]

You May Like